DOCK8 and Wiskott-Aldrich syndrome: Outcomes obtained with matched unrelated donors (MUD) have increasingly improved in the last decade and are approaching similar survival rates as with MSD [albeit with higher rate of HSCT-related complications (41)] [see review on Hematopoietic stem cell transplantation for WAS and DOCK8 deficiency (26)], allowing extended indications.